Literature DB >> 22365295

Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?

Anne M Covey1, Franz W Toro-Pape, Raymond H Thornton, Crystal Son, Joseph Erinjeri, Constantinos T Sofocleous, Lynn A Brody, Karen T Brown, Kent A Sepkowitz, Kent A Septkowitz, George I Getrajdman.   

Abstract

PURPOSE: To determine the rate of early infection for totally implantable venous access devices (TIVADs) placed without antibiotic prophylaxis.
MATERIAL AND METHODS: A list of patients who underwent TIVAD placement in 2009 was obtained from the patient archiving and communication system (PACS). This list was cross-referenced to all patients who underwent TIVAD removal from January 1, 2009, through January 30, 2010, to identify TIVADs that were removed within 30 days of placement. Retrospective chart review was performed to record patient demographics, including age, sex, cancer diagnosis, and indication for removal. Concurrent antibiotic therapy, chemotherapy, and laboratory data before and within 30 days of placement were recorded. Central line-associated bloodstream infections (CLABSIs) were identified using U.S. Centers for Disease Control and Prevention (CDC) criteria.
RESULTS: There were 1,183 ports placed and 13 removed. CLABSIs occurred in seven (0.6%) patients within 30 days of placement. At the time of TIVAD placement, 81 (7%) patients were receiving antibiotics incidental to the procedure. One patient who received an antibiotic the day of implantation developed a CLABSI. Chemotherapy was administered to 148 (13%) patients on the day of placement.
CONCLUSIONS: The rate of early infection without antibiotic prophylaxis before TIVAD placement in the interventional radiology suite is < 1%. Based on these data, use of prophylactic antibiotics for TIVAD placement is not recommended. Copyright Â
© 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22365295      PMCID: PMC6830723          DOI: 10.1016/j.jvir.2011.11.004

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  14 in total

1.  Prevention of intravascular catheter-related infections.

Authors:  L A Mermel
Journal:  Ann Intern Med       Date:  2000-03-07       Impact factor: 25.391

Review 2.  Antibiotic prophylaxis in interventional radiology.

Authors:  J Mark Ryan; Barbara M Ryan; Tony P Smith
Journal:  J Vasc Interv Radiol       Date:  2004-06       Impact factor: 3.464

3.  An intervention to decrease catheter-related bloodstream infections in the ICU.

Authors:  Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel
Journal:  N Engl J Med       Date:  2006-12-28       Impact factor: 91.245

Review 4.  Could antibiotic prophylaxis be not necessary to implant totally implantable venous access devices? Randomized prospective study.

Authors:  Isidoro Di Carlo; Adriana Toro; Elia Pulvirenti; Filippo Palermo; Giuseppe Scibilia; Stefano Cordio
Journal:  Surg Oncol       Date:  2009-10-12       Impact factor: 3.279

Review 5.  Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected].

Authors:  Aradhana M Venkatesan; Sanjoy Kundu; David Sacks; Michael J Wallace; Joan C Wojak; Steven C Rose; Timothy W I Clark; B Janne d'Othee; Maxim Itkin; Robert S Jones; Donald L Miller; Charles A Owens; Dheeraj K Rajan; Leann S Stokes; Timothy L Swan; Richard B Towbin; John F Cardella
Journal:  J Vasc Interv Radiol       Date:  2010-11       Impact factor: 3.464

6.  The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial.

Authors:  Hasan Karanlik; Sidika Kurul; Pinar Saip; Ersin Selcuk Unal; Fatma Sen; Rian Disci; Erkan Topuz
Journal:  Am J Surg       Date:  2011-05-23       Impact factor: 2.565

Review 7.  The problem with cephalosporins.

Authors:  S J Dancer
Journal:  J Antimicrob Chemother       Date:  2001-10       Impact factor: 5.790

8.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

9.  The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile.

Authors:  N S Ambrose; M Johnson; D W Burdon; M R Keighley
Journal:  J Antimicrob Chemother       Date:  1985-03       Impact factor: 5.790

10.  Combined ultrasound and fluoroscopy guided port catheter implantation--high success and low complication rate.

Authors:  Bernhard Gebauer; Michael El-Sheik; Michael Vogt; Hans-Joachim Wagner
Journal:  Eur J Radiol       Date:  2009-03       Impact factor: 3.528

View more
  7 in total

1.  Ultrasound-guided vein puncture versus surgical cut-down technique in totally implantable venous access devices (TIVADS): a prospective comparative study on safety, efficacy andcomplications.

Authors:  Giuseppe Cavallaro; Alessandro Sanguinetti; Olga Iorio; Giuseppe D'Ermo; Andrea Polistena; Nicola Avenia; Gianfranco Silecchia; Giorgio De Toma
Journal:  Int Surg       Date:  2014 Jul-Aug

Review 2.  Malignancy and Endocarditis: Divulging Into the Intertwined Association.

Authors:  Lakshmi Sree Pugalenthi; Mahlika Ahmad; Sanjana Reddy; Zineb Barkhane; Jalal Elmadi; Lakshmi Satish Kumar
Journal:  Cureus       Date:  2022-04-12

3.  Long-term outcomes of totally implantable venous access devices.

Authors:  Yi-Chia Wang; Pei-Lin Lin; Wei-Han Chou; Chih-Peng Lin; Chi-Hsiang Huang
Journal:  Support Care Cancer       Date:  2017-02-09       Impact factor: 3.603

4.  Comparison of PICC and TIVAP in chemotherapy for patients with thyroid cancer.

Authors:  Fangmei Qi; Hairong Cheng; Xiying Yuan; Li Zhang
Journal:  Oncol Lett       Date:  2020-06-15       Impact factor: 2.967

5.  Single-session versus two-session placement of chest port and gastrostomy tube in patients with head and neck cancer: Is there any difference in the device-related early infection rates?

Authors:  Philip Skummer; Katsuhiro Kobayashi; Mason Schoeneck; Jamynkumer Patel; Masoud Faridnia
Journal:  Acta Radiol Open       Date:  2021-08-29

6.  A Five-Year Data Report of Long-Term Central Venous Catheters Focusing on Early Complications.

Authors:  Harald Lenz; Kirsti Myre; Tomas Draegni; Elizabeth Dorph
Journal:  Anesthesiol Res Pract       Date:  2019-12-10

7.  Characteristics of infective endocarditis in a cancer population.

Authors:  Cullen Grable; Syed W Yusuf; Juhee Song; George M Viola; Owais Ulhaq; Jose Banchs; Corey T Jensen; Harsh Goel; Saamir A Hassan
Journal:  Open Heart       Date:  2021-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.